| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
|
Lancet Oncol
|
2012
|
1.93
|
|
2
|
Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG 0404.
|
Ann Surg
|
2014
|
1.32
|
|
3
|
Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study).
|
Jpn J Clin Oncol
|
2013
|
1.22
|
|
4
|
A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric Cancer (JCOG0912).
|
Jpn J Clin Oncol
|
2012
|
1.20
|
|
5
|
Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805).
|
Cancer Sci
|
2013
|
1.20
|
|
6
|
High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302.
|
Gastric Cancer
|
2013
|
1.16
|
|
7
|
Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma.
|
Ann Surg
|
2017
|
1.16
|
|
8
|
A phase II clinical trial of endoscopic submucosal dissection for early gastric cancer of undifferentiated type: Japan Clinical Oncology Group study JCOG1009/1010.
|
Jpn J Clin Oncol
|
2012
|
0.97
|
|
9
|
HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial).
|
Gastric Cancer
|
2014
|
0.86
|
|
10
|
A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002.
|
Jpn J Clin Oncol
|
2012
|
0.86
|
|
11
|
Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807).
|
Cancer Sci
|
2014
|
0.86
|
|
12
|
Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer: combined analysis of the Japan Clinical Oncology group trials JCOG9205 and JCOG9912.
|
Gastric Cancer
|
2013
|
0.85
|
|
13
|
Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303.
|
Medicine (Baltimore)
|
2016
|
0.84
|
|
14
|
Prognostic Factors in Patients Receiving Neoadjuvant 5-Fluorouracil plus Cisplatin for Advanced Esophageal Cancer (JCOG9907).
|
Oncology
|
2015
|
0.82
|
|
15
|
Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912.
|
Oncologist
|
2014
|
0.82
|
|
16
|
Prognostic Impact of Postoperative Morbidity After Esophagectomy for Esophageal Cancer: Exploratory Analysis of JCOG9907.
|
Ann Surg
|
2017
|
0.82
|
|
17
|
Green tea consumption and breast cancer risk in Japanese women: a case-control study.
|
Nutr Cancer
|
2013
|
0.81
|
|
18
|
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).
|
Cancer Chemother Pharmacol
|
2012
|
0.81
|
|
19
|
The Prevalence of Overall and Initial Lymph Node Metastases in Clinical T1N0 Thoracic Esophageal Cancer: From the Results of JCOG0502, a Prospective Multicenter Study.
|
Ann Surg
|
2016
|
0.79
|
|
20
|
Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A).
|
Gastric Cancer
|
2014
|
0.78
|
|
21
|
Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
|
Ann Surg
|
2017
|
0.76
|